121 related articles for article (PubMed ID: 12649411)
1. Dose reduction of etanercept--can we treat more patients using a fixed budget?
Clunie G; Voules S; Watts R
Rheumatology (Oxford); 2003 Apr; 42(4):600-1. PubMed ID: 12649411
[No Abstract] [Full Text] [Related]
2. Marked regression of pulmonary rheumatoid nodules under etanercept therapy.
Derot G; Marini-Portugal A; Maitre B; Claudepierre P
J Rheumatol; 2009 Feb; 36(2):437-9. PubMed ID: 19208569
[No Abstract] [Full Text] [Related]
3. Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis.
Kaiser M-; Bozonnat M-; Jorgensen C; Daurès J-; Sany J
Arthritis Rheum; 2002 Feb; 46(2):559-60. PubMed ID: 11840464
[No Abstract] [Full Text] [Related]
4. Defining the value of structural inhibition. Is low-dose etanercept inferior to the standard dose?
Ruderman EM
Rheumatology (Oxford); 2012 Dec; 51(12):2118-9. PubMed ID: 23024059
[No Abstract] [Full Text] [Related]
5. Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?
Tiliakos AN; Tiliakos NA
J Rheumatol; 2003 Dec; 30(12):2727. PubMed ID: 14719226
[No Abstract] [Full Text] [Related]
6. Reduction of biological agent dose in rheumatic diseases: descriptive analysis of 153 patients in clinical practice conditions.
Inciarte-Mundo J; Hernández MV; Rosario V; Ruiz-Esquide V; Cabrera-Villalba S; Ramírez J; Cañete JD; Sanmartí R
Reumatol Clin; 2014; 10(1):10-6. PubMed ID: 23876791
[TBL] [Abstract][Full Text] [Related]
7. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.
van Herwaarden N; van der Maas A; Minten MJ; van den Hoogen FH; Kievit W; van Vollenhoven RF; Bijlsma JW; van den Bemt BJ; den Broeder AA
BMJ; 2015 Apr; 350():h1389. PubMed ID: 25858265
[TBL] [Abstract][Full Text] [Related]
8. Etanercept tapering in rheumatoid arthritis.
Graudal N; Jürgens G
N Engl J Med; 2015 Jan; 372(5):489. PubMed ID: 25629752
[No Abstract] [Full Text] [Related]
9. Use of etanercept in a patient with rheumatoid arthritis on hemodialysis.
Sugioka Y; Inui K; Koike T
Mod Rheumatol; 2008; 18(3):293-5. PubMed ID: 18299957
[TBL] [Abstract][Full Text] [Related]
10. Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose.
Raffeiner B; Botsios C; Ometto F; Bernardi L; Stramare R; Todesco S; Sfriso P; Punzi L
Clin Exp Rheumatol; 2015; 33(1):63-8. PubMed ID: 25535985
[TBL] [Abstract][Full Text] [Related]
11. Etanercept tapering in rheumatoid arthritis.
Emery P; Hammoudeh M; Combe B
N Engl J Med; 2015 Jan; 372(5):489-90. PubMed ID: 25629751
[No Abstract] [Full Text] [Related]
12. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNFalpha treatment in Italian patients.
Benucci M; Li Gobbi F; Sabadini L; Saviola G; Baiardi P; Manfredi M
Int J Immunopathol Pharmacol; 2009; 22(4):1147-52. PubMed ID: 20074482
[TBL] [Abstract][Full Text] [Related]
13. Lethal medium-vessel panarteritis mimicking deep sepsis following etanercept and minocycline therapy in a patient with severe rheumatoid arthritis.
Berthelot JM; Glemarec J; Maugars Y; Prost A
Rheumatology (Oxford); 2002 Jun; 41(6):703-5. PubMed ID: 12048303
[No Abstract] [Full Text] [Related]
14. Etanercept and methotrexate in rheumatoid arthritis.
Poteliakhoff A
Lancet; 2004 May; 363(9422):1734. PubMed ID: 15158644
[No Abstract] [Full Text] [Related]
15. [Therapy of rheumatoid arthritis with etanercept].
Lamprecht P; Nitschmann S
Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
[No Abstract] [Full Text] [Related]
16. Is once a week enough?
Bawa S; Hall J; Edmonds S; Webley M
J Rheumatol; 2007 Aug; 34(8):1783; author reply 1783-4. PubMed ID: 17902205
[No Abstract] [Full Text] [Related]
17. 25 mg etanercept once weekly in rheumatoid arthritis and spondylarthropathy.
Berthelot JM; Varin S; Cormier G; Tortellier L; Guillot P; Glemarec J; Maugars Y
Joint Bone Spine; 2007 Mar; 74(2):144-7. PubMed ID: 17337351
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice.
Ramírez-Herráiz E; Escudero-Vilaplana V; Alañón-Plaza E; Trovato-López N; Herranz-Alonso A; Morell-Baladrón A; Sanjurjo-Sáez M
Clin Exp Rheumatol; 2013; 31(4):559-65. PubMed ID: 23710583
[TBL] [Abstract][Full Text] [Related]
19. Missing the obvious.
Nuenninghoff DM
J Rheumatol; 2009 Aug; 36(8):1833; author reply 1833. PubMed ID: 19671823
[No Abstract] [Full Text] [Related]
20. [Combination drug therapy in rheumatoid arthritis].
Kawai S
Nihon Rinsho; 2005 Jan; 63 Suppl 1():549-55. PubMed ID: 15799416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
